$BBh(B15$B2s3X=Q=82q(B

$BF|;~!'(B2001 $BG/(B 12 $B7n(B 1 $BF|!JEZ!K!!(B13:00-17:10
$B>l=j!'(B$BJ<8K0e2JBg3X(B3$B9f4[(B
$BEvHV@$OC?M!'(B$B@>>eN4G7!JJ<8K0e2JBg3XBhFsIBM}!K(B

$B%9%i%$%I%;%_%J!C2=4I$NIBM}!W(B

Moderator$B!'@P9u?.8c!JBg:eI\N)@.?MIB%;%s%?!

1. $B>C2=4I0-@->eN4G7!JJ<8K0e2JBg3XBhFsIBM}!K(B
2. $B>C2=4I0-@-$BBgD2NI@-%]%j!<%W$N?GCG(B$B!!9>F,M3B@O:!JBg:e0e2JBg3XBh0lIBM}!K(B

$B>INc8!F$2q(B

$B>INcHV9f5Z$S1iBjL>!J(B*$B!V?GCGIBM}!W$K7G:\M=Dj>INc!K(B

1. *ATL$B$N2=3XNEK!Cf$KGEI$H$J$C$?#1K68!Nc(B
   strongyloidiasis
2. *$B4N hepatocellular carcinoma with neuroendocrine differentiation
3. *$B9E8}38$KH/@8$7$?9|7gB;$rH<$& vascular malformation
4. *$B1&:A9|ItFpIt low-grade fibromyxoid sarcoma
5. *$BB?:L$JJ,2=798~$r<($7$?0_4b$r4^$`;M=E4b$N0lK68!Nc(B
   multiple carcinomas

$B302JIBM}>INc8!F$2q!&8!F$>INc(B$B!JMW%Q%9%o!<%I!K(B